EndoGastric Solutions
San Mateo, US · Founded 1987 · Delaware corporation · 3,551 employees on LinkedIn · 13 known investors
Find your way into EndoGastric Solutions
Sign up to see every warm intro you have to EndoGastric Solutions
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EndoGastric Solutions team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.
Founders & leadership

Board



Investors · 13
How we know: Accelmed Partners's portfolio page · board seat on SEC Form D · Not right? Tell us
How we know: Canaan Partners's portfolio page · a partner's Signal profile · board seat on SEC Form D · funding news · geekwire.com · Not right? Tell us
How we know: Lightstone Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · geekwire.com · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$110.6M disclosed across 6 of 9 rounds · 2012–2020
- Undisclosed amountSeries IMay 2019Source ↗
▶$27MraisedDec 2021 · 32 investors · Other Health CareRule 506(b)
- Louis BaldinoExecutive Officer, Director
- Darren CrowExecutive Officer
- Michael CarusiDirector
- Theodore StephensExecutive Officer
- Brent AhrensDirector
- Alejandro SanchezDirector
- John GillingsDirector
- Michael BurkeExecutive Officer
- Kunal PaymasterDirector
- Martin ReidExecutive Officer
- Offering amount
- $45M
- Amount sold
- $27M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$40.6MraisedJun 2019 · 31 investors · Other Health CareRule 506(b)
- Arda MinocherhomjeeDirector
- Uri GeigerDirector
- Theodore StephensExecutive Officer
- Martin ReidExecutive Officer
- Darren CrowExecutive Officer
- Michael BurkeExecutive Officer
- Louis BaldinoExecutive Officer, Director
- Philip MacdonaldExecutive Officer
- Jordan DavisDirector
- Brent AhrensDirector
- Kunal PaymasterDirector
- Alejandro SanchezDirector
- Michael CarusiDirector
- Offering amount
- $40.6M
- Amount sold
- $40.6M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10MraisedMay 2015 · 17 investors · BiotechnologyRule 506(b)
- Michael CarusiDirector
- Scott WardDirector
- Arda MinocherhomjeeDirector
- Philip MacdonaldExecutive Officer
- Brent AhrensDirector
- Jordan DavisDirector
- Lee Wrubel, M.D.Director
- Louis BaldinoExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $10M
- First sale
- May 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedApr 2015 · 13 investors · BiotechnologyRule 506(b)
- Michael CarusiDirector
- Scott WardDirector
- Skip BaldinoExecutive Officer, Director
- Arda MinocherhomjeeDirector
- Jordan DavisDirector
- Brent AhrensDirector
- Philip MacdonaldExecutive Officer
- Lee Wrubel, M.D.Director
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- Minimum investment
- $1.8K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$30.6MraisedMay 2014 · 16 investors · BiotechnologyRule 506(b)
- Guy JordanDirector
- Scott WardDirector
- Robert Michael KleineDirector
- Arda MinocherhomjeeDirector
- Brent AhrensDirector
- Lilip LauExecutive Officer
- Jordan DavisDirector
- Lee Wrubel, M.D.Director
- Josh DeFonzoExecutive Officer
- Skip BaldinoExecutive Officer
- Floyd Loop, M.D.Director
- Michael CarusiDirector
- Offering amount
- $30.7M
- Amount sold
- $30.6M
- Minimum investment
- $33.9K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1MraisedApr 2014 · 14 investors · BiotechnologyRule 506(b)
- Michael CarusiDirector
- Lilip LauExecutive Officer
- Scott WardDirector
- Guy JordanDirector
- Floyd Loop, M.D.Director
- Josh DeFonzoExecutive Officer
- Arda MinocherhomjeeDirector
- Brent AhrensDirector
- Lee Wrubel, M.D.Director
- Jordan DavisDirector
- Robert Michael KleineDirector
- Offering amount
- $1M
- Amount sold
- $1M
- Minimum investment
- $3.2K
- First sale
- Apr 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
4 people who came through EndoGastric Solutions went on to found or lead other companies.
In the news
Frequently asked questions
- What does EndoGastric Solutions do?
- EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices. The company, now associated with Merit Medical, serves gastroenterology and surgical providers performing anti-reflux procedures.
- Who are EndoGastric Solutions's investors?
- EndoGastric Solutions's investors include Accelmed Partners, Canaan Partners, Evidity Health Capital, Lightstone Ventures, VCFA Group, Advanced Technology Ventures, De Novo Ventures, FOUNDATION MEDICAL PARTNERS and 1 more.
- How much funding has EndoGastric Solutions raised?
- EndoGastric Solutions has disclosed $110.6M raised across 6 of its 9 known rounds.
- Where is EndoGastric Solutions headquartered?
- EndoGastric Solutions is headquartered in San Mateo, US.




